Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib as first- line systemic therapy in patients with intermediate- stage hccToshifumi Tada, Takashi Kumada,Atsushi Hiraoka, Masashi Hirooka,Kazuya Kariyama, Ei Itobayashi, Tsuji Kunihiko, Toru Ishikawa, Hidenori Toyoda, Takeshi Hatanaka,Satoru Kakizaki,Fujimasa Tada,Hideko Ohama,Kazuhiro Nouso,Tomomitsu Matono,Yutaka Yata,Yoichi Hiasa,Masatoshi KudoHEPATOLOGY（2023）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
